These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36288041)

  • 1.
    Reta MA; Tamene BA; Abate BB; Mensah E; Maningi NE; Fourie PB
    Trop Med Infect Dis; 2022 Oct; 7(10):. PubMed ID: 36288041
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of drug resistance-conferring mutations associated with isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Ethiopia: a systematic review and meta-analysis.
    Reta MA; Alemnew B; Abate BB; Fourie PB
    J Glob Antimicrob Resist; 2021 Sep; 26():207-218. PubMed ID: 34214698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?
    Denkinger CM; Pai M; Dowdy DW
    PLoS One; 2014; 9(1):e84197. PubMed ID: 24404155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing Mycobacterium tuberculosis isolates from Karachi, Pakistan: drug resistance and genotypes.
    Ayaz A; Hasan Z; Jafri S; Inayat R; Mangi R; Channa AA; Malik FR; Ali A; Rafiq Y; Hasan R
    Int J Infect Dis; 2012 Apr; 16(4):e303-9. PubMed ID: 22365136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda.
    Micheni LN; Kassaza K; Kinyi H; Ntulume I; Bazira J
    PLoS One; 2021; 16(10):e0259221. PubMed ID: 34714879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings.
    Liu Z; Dong H; Wu B; Zhang M; Zhu Y; Pang Y; Wang X
    J Infect; 2019 Oct; 79(4):349-356. PubMed ID: 31400354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome.
    Girum T; Muktar E; Lentiro K; Wondiye H; Shewangizaw M
    Trop Dis Travel Med Vaccines; 2018; 4():5. PubMed ID: 29942536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
    Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing drug resistance of Mycobacterium tuberculosis isolates in a medical center in northern Taiwan.
    Su WJ; Feng JY; Huang CC; Perng RP
    J Formos Med Assoc; 2008 Mar; 107(3):259-64. PubMed ID: 18400612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
    Bisimwa BC; Nachega JB; Warren RM; Theron G; Metcalfe JZ; Shah M; Diacon AH; Sam-Agudu NA; Yotebieng M; Bulabula ANH; Katoto PDMC; Chirambiza JP; Nyota R; Birembano FM; Musafiri EM; Byadunia S; Bahizire E; Kaswa MK; Callens S; Kashongwe ZM
    Clin Infect Dis; 2021 Jul; 73(2):e362-e370. PubMed ID: 32590841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.
    Adane K; Ameni G; Bekele S; Abebe M; Aseffa A
    BMC Public Health; 2015 Jun; 15():572. PubMed ID: 26092570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya.
    Ogwang MO; Imbuga M; Ngugi C; Mutharia L; Magoma G; Diero L
    BMC Infect Dis; 2021 Nov; 21(1):1175. PubMed ID: 34809602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
    Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
    BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abbott RealTime MTB and MTB RIF/INH assays for the diagnosis of tuberculosis and rifampicin/isoniazid resistance.
    Wang MG; Xue M; Wu SQ; Zhang MM; Wang Y; Liu Q; Sandford AJ; He JQ
    Infect Genet Evol; 2019 Jul; 71():54-59. PubMed ID: 30902741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran.
    Nasiri MJ; Zamani S; Pormohammad A; Feizabadi MM; Aslani HR; Amin M; Halabian R; Imani Fooladi AA
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):9-14. PubMed ID: 28823010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India.
    Khurana P; Saigal K; Ghosh A
    Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis.
    Goyal V; Kadam V; Narang P; Singh V
    BMC Public Health; 2017 Oct; 17(1):817. PubMed ID: 29041901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.